Gut microbial signatures and immunotherapy outcomes in NSCLC and melanoma: a systematic review and meta-analysis
Abstract Background The composition of the gut microbiome has been linked to clinical responses to immune checkpoint inhibitors (ICIs), but its prognostic association with outcomes in non-small cell lung cancer (NSCLC) and melanoma remains incompletely defined. We performed a systematic review and m...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2026-02-01
|
| Серии: | BMC Cancer |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s12885-026-15763-3 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
